CFPCarlo Federico PernoMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023Diagnosis Respiratory Viruses: Point-of-Care Testing & PCR | Carlo Federico PernoView Slideset
SFSlim FouratiMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023State-of-the-Art: RSV - Prevention & Treatment | Slim FouratiView Slideset
DHSTDarrell H. S. TanMD, FRCPC, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023HIV Prevention: Barriers and Facilitators of PrEP Access | Darrell H. S. TanView Slideset
SFSlim FouratiMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023Different Algorithms and Websites for Virus Evolution and Resistance Interpretation | Slim FouratiView Slideset
MSMaria SantoroPhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023Clinical Relevance and Real Practice Use of HIV-1 NGS Results | Maria SantoroView Slideset
CCCharlotte CharpentierPharmD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023The Clinical Relevance of Integrase Resistance | Charlotte CharpentierView Slideset
MGMonica GandhiMD, MPHSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023Practical/Clinical Considerations When Prescribing LA-ARVs | Monica GandhiView Slideset
HGHarmony GargesMD, MPHSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023ViiV | Harmony GargesView Slideset
RECRafael Eduardo CampoMDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023Merck/MSD | Rafael Eduardo CampoView Slideset
CRChristophe RodriguezPharmD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2023Emerging Data on Hepatitis E | Christophe RodriguezView Slideset
JMSJörn M. SchattenbergMDSlidesetViral Hepatitis and Liver DiseaseInnovations in NAFLD Care Workshop 2023101 Biomarker in Fibrotic Liver Disease OR the Armamentarium of Non-invasive Test to Stage Liver Disease - Jörn Schattenberg, MDView Slideset
JMSJörn M. SchattenbergMDSlidesetViral Hepatitis and Liver DiseaseInnovations in NAFLD Care Workshop 2023101 Biomarker in Fibrotic Liver Disease OR the Armamentarium of Non-invasive Test to Stage Liver Disease - Jörn Schattenberg, MD slidesetsView Slideset
